161 results
6-K
EX-99.1
GLPG
Galapagos NV
30 May 24
Current report (foreign)
4:44pm
of dosing in the proof-of-concept trial. Adaptimmune will be responsible for the clinical proof-of-concept trial in head & neck cancer and the supply … of the vector for the manufacturing of uza-cel. Galapagos will be responsible for the delivery of fresh uza-cel product for the head & neck cancer proof
6-K
EX-99.8
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
including the financial and accounting data
The administrative body is responsible for:
drawing up a report that:
in accordance with article 7:180 CCA … of the financial and accounting data included in the report of the administrative body consists of making inquiries, primarily to persons responsible
6-K
EX-99.3
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
immediately before the start of the Shareholders’ Meetings.
Data protection
The Company is responsible for the processing of personal data it receives from
6-K
EX-99.6
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
assumptions.
Responsibilities of administrative body for the drafting of the annual accounts
The administrative body is responsible … , whether due to fraud or error.
In preparing the annual accounts, the administrative body is responsible for assessing the Company’s ability to continue
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
in Europe. Gilead is responsible for the commercialization and distribution of Jyseleca® outside of Europe, including in Japan where Jyseleca® … ) is responsible for the distribution and commercialization of Jyseleca®.
Jyseleca® reimbursement in RA in Europe Jyseleca® in RA is currently reimbursed
6-K
EX-99.15
e87vcj eyz75fi
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
S-8
EX-99.1
eg5zpu14pvh efw8f0ed
4 Dec 23
Registration of securities for employees
5:16pm
S-8
EX-99.2
3ugko
4 Dec 23
Registration of securities for employees
5:16pm
S-8
EX-99.3
clsrj
4 Dec 23
Registration of securities for employees
5:16pm
S-8
EX-4.1
gxhq1x04eyo zfauu
4 Dec 23
Registration of securities for employees
5:16pm